PTHS PTHS License and collaboration revenues — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTHS in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTHS's license and collaboration revenues — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTHS's license and collaboration revenues — total revenue?
- PTHS (PTHS) reported license and collaboration revenues — total revenue of $241K in Q1 2026.
- What does license and collaboration revenues — total revenue mean?
- This metric represents the total revenue recognized from licensing intellectual property and entering into strategic collaboration agreements with third-party partners. It captures income streams derived from upfront payments, milestone achievements, and royalties associated with the development and commercialization of therapeutic assets. This revenue category is a key indicator of a biotechnology company's ability to monetize its research pipeline and validate its scientific platform through external partnerships.